Poorer OSs were associated with patient groups with low CRBN expression in breast cancer (HR = 0.45, p = 6.8 × 10−0.7; Figure 2a) and lung cancer (HR = 0.39, p < 1 × 10−16; Figure 2b). Here, CRBN is linked to lung cancer.